ArticleThe Journal of international medical research2025
Case report: False-positive B-type natriuretic peptide results with the cyclic amplified fluorescence immunoassay.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Averting Potential Misinterpretations and Diagnostic Misapplications of Misleading Laboratory Results.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
B-type natriuretic peptide, which was initially isolated from porcine brain tissue, has been used in the clinic as an important indicator for the diagnosis, risk stratification, and prognosis of heart failure. In recent years, many commercial immunoassays to assess B-type natriuretic peptide have been reported to undergo interference due to various factors. At present, the commonly used assays to assess B-type natriuretic peptide are enzyme-linked immunosorbent assay and direct chemiluminescence, which are based on a "sandwich structure" formed by dual antibodies; both assays have been reported to undergo interference. We report the case of a patient whose B-type natriuretic peptide results, which were detected using a cyclic amplified fluorescence immunoassay, were false-positive. The patient had a low-risk pulmonary embolism without right heart failure; however, her B-type natriuretic peptide results were surprisingly high. Further study confirmed that the abnormal B-type natriuretic peptide result was caused by the interference of the human anti-mouse antibodies. Therefore, when encountering B-type natriuretic peptide results that are not consistent with the clinical situation, the possibility of interference in the assay should be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.